GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Renascience Inc (TSE:4889) » Definitions » Total Stockholders Equity

Renascience (TSE:4889) Total Stockholders Equity : 円1,533.8 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Renascience Total Stockholders Equity?

Renascience's Total Stockholders Equity for the quarter that ended in Sep. 2024 was 円1,533.8 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Renascience's Book Value per Share for the quarter that ended in Sep. 2024 was 円120.65. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Renascience's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.24.

Renascience Total Stockholders Equity Historical Data

The historical data trend for Renascience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renascience Total Stockholders Equity Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Total Stockholders Equity
621.59 561.53 2,200.86 1,865.06 1,606.72

Renascience Quarterly Data
Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,867.23 1,769.74 1,642.58 1,606.72 1,533.76

Renascience  (TSE:4889) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Renascience's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1533.755-0)/12.712
=120.65

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Renascience's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 365.577) / 1533.755
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renascience Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Renascience's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Renascience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Renascience Inc (TSE:4889) » Definitions » Total Stockholders Equity
Comparable Companies
TSE:7777 TSE:7600 TSE:6678 TSE:9341 TSE:7792 TSE:6823 TSE:4890 TSE:3079 TSE:7963 TSE:5187 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
2-3-6 Nihombashi-Honcho, Chuo-ku, Tokyo, JPN, 103-0023
Website
https://www.renascience.co.jp
Renascience Inc is engaged in the research and development of new medical solutions by utilizing various modalities such as pharmaceuticals, medical devices, artificial intelligence and others to solve problems in the medical setting.

Renascience Headlines

No Headlines